Bradykinin B1 receptor antagonists as potential therapeutic agents for pain

Journal of Medicinal Chemistry

Volumn 53, Issue 15, 2010, Pages 5383-5399

  Huang, Hui ^a   Player, Mark R ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST;

ANALGESIA; DRUG ACTIVITY; DRUG INDICATION; DRUG MECHANISM; HUMAN; NONHUMAN; PAIN; REVIEW;

AMIDES; ANALGESICS; ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, MOLECULAR; PAIN; RECEPTOR, BRADYKININ B1; SULFONAMIDES;

EID: 77955372107     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1000776     Document Type: Review

References (110)

1. Leeb-Lundberg, L. M. F.; Marceau, F.; Muller-Esterl, W.; Pettibone, D. J.; Zuraw, B. L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol. Rev. 2005, 57, 27-77
2. Rocha e Silva, M.; Beraldo, W. T.; Rosenfeld, G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma by snake venoms and by trypsin Am. J. Physiol. 1949, 156, 261-273
3. Merrifield, R. B. Solid phase synthesis. III. An improved synthesis of bradykinin Biochemistry 1964, 3, 1385-1390
4. Blais, C., Jr.; Marceau, F.; Rouleau, J. L.; Adam, A. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins Peptides 2000, 21, 1903-1940
5. Rocha e Silva, M. Kinin Hormones; Charles C. Thomas Publisher, Ltd.: Springfield, IL, 1970.
6. Marceau, F.; Hess, J. F.; Bachvarov, D. R. The B1 receptors for kinins Pharmacol. Rev. 1998, 50, 357-386
7. Linz, W.; Wiemer, G.; Gohlke, P.; Unger, T.; Schoelkens, B. A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors Pharmacol. Rev. 1995, 47, 25-49
8. Gainer, J. V.; Morrow, J. D.; Loveland, A.; King, D. J.; Brown, N. J. Effect of bradykinin-receptor blockade on the response to angiotensin- converting-enzyme inhibitor in normotensive and hypertensive subjects N. Engl. J. Med. 1998, 339, 1285-1292
9. Marceau, F.; Regoli, D. Bradykinin receptor ligands: therapeutic perspectives Nat. Rev. Drug Discovery 2004, 3, 845-852
10. Howl, J.; Payne, S. J. Bradykinin receptors as a therapeutic target Expert Opin. Ther. Targets 2003, 7, 277-285
11. Davis, A. J.; Perkins, M. N. Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat Neuropharmacology 1994, 33, 127-133
12. Figueroa, C. D.; Marchant, A.; Novoa, U.; Försteermann, U.; Jarnagin, K.; Schölkens, B.; Müller-Esterl, W. Differential distribution of bradykinin B2 receptors in the rat and human cardiovascular system Hypertension 2001, 37, 110-120
13. 10-kallidin engagement of the B1 receptor stimulates type I collagen synthesis via stabilization of connective tissue growth factor mRNA J. Biol. Chem. 2000, 275, 12475-12480
14. Wu, J.; Akaike, T.; Hayashida, K.; Miyamoto, Y.; Nakagawa, T.; Miyakawa, K.; Müller-Esterl, W.; Maeda, H. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues Int. J. Cancer 2002, 98, 29-35
15. Taub, J. S.; Guo, R.; Leeb-Lundberg, L. M. F.; Madden, J. F.; Daaka, Y. Bradykinin receptor subtype 1 expression and function in prostate cancer Cancer Res. 2003, 63, 2037-2041
16. Regoli, D.; Barabé, J.; Park, W. K. Receptors for bradykinin in rabbit aortae Can. J. Physiol. Pharmacol. 1977, 55, 855-867
17. Regoli, D.; Marceau, F.; Barabé, J. De novo formation of vascular receptors for bradykinin Can. J. Physiol. Pharmacol. 1978, 56, 674-677
18. Drouin, J. N.; St. Pierre, S. A.; Regoli, D. Receptors for bradykinin and kallidin Can. J. Physiol. Pharmacol. 1979, 57, 375-379
19. Calixto, J. B.; Medeiros, R.; Fernandes, E. S.; Ferreira, J.; Cabrini, D. A.; Campos, M. M. Kinin B1 receptor: key G-protein-coupled receptors and their role in inflammatory and painful processes Br. J. Pharmacol. 2004, 143, 803-818
20. Ma, Q. P.; Heavens, R. Basal expression of bradykinin B1 receptors in the spinal cord in humans and rats NeuroReport 2001, 12, 2311-2314
21. Wotherspoon, G.; Winter, J. Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system Neurosci. Lett. 2000, 294, 175-178
22. Marceau, F.; Bachvarov, D. R. Kinin receptors Clin. Rev. Allergy Immunol. 1998, 16, 385-401
23. Ahluwalia, A.; Perretti, M. B1 receptors as a new inflammatory target. Could this B the 1? Trends Pharmacol. Sci. 1999, 20, 100-104
24. Heitsch, H. The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease Expert Opin. Invest. Drugs 2003, 12, 759-770
25. Alfie, M. E.; Sigmon, D. H.; Pomposiello, S. I.; Carretero, O. A. Effect of high salt intake in mutant mice lacking bradykinin B2 receptors Hypertension 1997, 29, 483-487
26. Abraham, W. M.; Scuri, M.; Farmer, S. G. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease Eur. J. Pharmacol. 2006, 533, 215-221
27. Pesquero, J. B.; Araujo, R. C.; Heppenstall, P. A.; Stucky, C. L.; Silva, J. A., Jr.; Walther, T.; Oliviera, S. M.; Pesquero, J. L.; Paiva, A. C. M.; Calixton, J. B.; Lewin, G. R.; Bader, M. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 8140-8145
28. Wang, P. H.; Cenedeze, M. A.; Campanholle, G.; Malheiros, D. M.; Torres, H. A.; Pesquero, J. B.; Pacheco-Silva, A.; Camara, N. O. Deletion of bradykinin B1 receptor reduces renal fibrosis Int. Immunopharmacol. 2009, 96, 653-657
29. Ferreira, J.; Campos, M. M.; Pesquero, J. B.; Araujo, R. C.; Bader, M.; Calixto, J. B. Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 knockout mice Neuropharmacology 2001, 41, 1006-1012
30. Ferreira, J.; Beirith, A.; Mori, M. A. S.; Araujo, R. C.; Bader, M.; Pesquero, J. B.; Calixto, J. B. Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice J. Neurosci. 2005, 25, 2405-2412
31. Westermann, D.; Walther, T.; Savvatis, K.; Escher, F.; Sobirey, M.; Riad, A.; Bader, M.; Schultheiss, H.-P.; Tschope, C. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy Diabetes 2009, 58, 1373-1381
32. Petcu, M.; Dias, J. P.; Ongali, B.; Thibault, G.; Neugebauer, W.; Couture, R. Role of kinin B1 and B2 receptors in a rat model of neuropathic pain Int. Immunopharmacol. 2008, 8, 188-196
33. Levy, D.; Zochodne, D. W. Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain Pain 2000, 86, 265-271
34. Gabra, B. H.; Sirois, P. Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice Eur. J. Pharmacol. 2002, 457, 115-124
35. Bujalska, M.; Tatarkiewicz, J.; Gumulka, S. W. Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy Pharmacology 2008, 81, 158-163
36. Couture, R.; Lindsey, C. J. Brain Kallikrein-Kinin System: From Receptors to Neuronal Pathways and Physiological Functions. In Handbook of Chemical Neuroanatomy; Quirion, R.; Björklund, A.; Hökfelt, T., Eds.; Elsevier Science B.V.: Amsterdam, 2000; Vol. 16, p 241.
37. Shughrue, P. J.; Ky, B.; Austin, C. P. Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization study J. Comp. Neurol. 2003, 465, 372-384
38. Fox, A.; Wotherspoon, G.; McNair, K.; Hudson, L.; Patel, S.; Gentry, C.; Winter, J. Regulation and function of spinal and peripheral neuronal B1 receptors in inflammatory mechanical hyperalgesia Pain 2003, 104, 683-691
39. Gougat, J.; Ferrari, B.; Sarran, L.; Planchenault, C.; Poncelet, M.; Maruani, J.; Alonso, R.; Cudennec, A.; Croci, T.; Guagnini, F.; Urban-Szabo, K.; Martinolle, J.-P.; Soubrié, P.; Finance, O.; Le Fur, G. SSR240612 [(2 R)-2-[((3 R)-3-(1,3-benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino} propanoyl)amino]-3-(4-{[2 R,6 S)-2,6-dimethylpiperidinyl]methyl}phenyl)- N -isopropyl- N -methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization J. Pharmacol. Exp. Ther. 2004, 309, 661-669
40. Boyce, S.; Chan, C.-C.; Gordon, R.; Li, C.-S.; Rodger, I. W.; Webb, J. K.; Rupniak, N. M. J.; Hill, R. G. L-745,337: A selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats Neuropharmacology 1994, 33, 1609-11
41. Ni, A.; Chai, K. X.; Chao, L.; Chao, J. Molecular cloning and expression of rat bradykinin B1 receptor Biochim. Biophys. Acta 1998, 1442, 177-185
42. Macneil, T; Feighner, S.; Hreniuk, D. L.; Hess, J. F.; Van Der Ploeg, L. H. T. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors Can. J. Physiol. Pharmacol. 1997, 75, 735-740
43. Su, D.-S.; Markowitz, M. K.; DiPardo, R. M.; Murphy, K. L.; Harrell, C. M.; O'Malley, S. S.; Ransom, R. W.; Chang, R. S. L.; Ha, S.; Hess, F. J.; Pettibone, D. J.; Mason, G. S.; Boyce, S.; Freidinger, R. M.; Bock, M. G. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist J. Am. Chem. Soc. 2003, 125, 7516-7517
44. Hess, J. F.; Ransom, R. W.; Zeng, Z.; Chang, R. S. L.; Hey, P. J.; Warren, L.; Harrell, C. M.; Murphy, K. L.; Chen, T.-B.; Miller, P. J.; Lis, E.; Reiss, D.; Gibson, R. E.; Markowitz, M. K.; Dipardo, R. M.; Su, D.-S.; Bock, M. G.; Gould, R. J.; Pettibone, D. J. Generation and characterization of a human bradykinin B1 transgenic rat as a pharmacodynamic model J. Pharmacol. Exp. Ther. 2004, 310, 488-497
45. 1 receptor antagonists J. Med. Chem. 2004, 47, 6439-6442
46. Kuduk, S. D.; Di Marco, C. N.; Chang, R. K.; Wood, M. R.; Schirripa, K. M.; Kim, J. J.; Wai, J. M. C.; DiPardo, R. M.; Murphy, K. L.; Ransom, R. W.; Harrell, C. M.; Reiss, D. R.; Holahan, M. A.; Cook, J.; Hess, J. F.; Sain, N.; Urban, M. O.; Tang, C.; Prueksaritanont, T.; Pettibone, D. J.; Bock, M. G. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists J. Med. Chem. 2007, 50, 272-282
47. Mason, G. S.; Cumberbatch, M. J.; Hill, R. G.; Rupniak, N. M. J. The bradykinin B1 receptor antagonist B9858 inhibits a nociceptive spinal reflex in rabbits Can. J. Physiol. Pharmacol. 2002, 804, 264-268
48. Whalley, E. T.; Clegg, S.; Stewart, J. M.; Vavrek, R. J. The effect of kinin agonists and antagonists on the pain response of the human blister base Naunyn-Schmiedeberg's Arch. Pharmacol. 1987, 336, 652-655
49. Akbary, A. M.; Wirth, K. J.; Schölkens, B. A. Efficacy and tolerability of icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma Immunopharmacology 1996, 33, 238-242
50. Proud, D.; Bathon, J. M.; Togias, A. G.; Naclerio, R. M. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action Can. J. Physiol. Pharmacol. 1995, 73, 820-826
51. Turner, P.; Dear, J.; Scadding, G.; Foreman, J. C. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen J. Allergy Clin. Immunol. 2001, 107, 105-113
52. Fein, A. M.; Bernard, G. R.; Criner, G. J.; Fletcher, E. C.; Good, J. T., Jr.; Knaus, W. A.; Levy, H.; Matuschak, G. M.; Shanies, H. M.; Taylor, R. W.; Rodell, T. C. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127); results of a randomized, double-blind, placebo-controlled trial JAMA, J. Am. Med. Assoc. 1997, 277, 482-487
53. Regoli, D.; Allogho, S. N.; Rizzi, A.; Gobeil, F. J. Bradykinin receptors and their antagonists Eur. J. Pharmacol. 1998, 348, 1-10
54. Stewart, J. M. Bradykinin antagonists: discovery and development Peptides 2004, 25, 527-532
55. Ferrari, B.; Gougat, J.; Muneaux, C.; Muneaux, Y.; Perreaut, P.; Planchenault, C. Novel N -(Arylsulfonyl) Amino Acid Derivatives Having Bradykinin Receptor Affinity. U.S. Patent 6,015,812, 2002.
56. Pietrovski, E. F.; Otuki, M. F.; Regoli, D.; Bader, M.; Pesquero, J. B.; Cabrini, D. A.; Zampronio, A. R. The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation Regul. Pept. 2009, 152, 67-72
57. D'Amico, D. C.; Aya, T.; Human, J.; Fotsch, C.; Chen, J. J.; Biswas, K.; Riahi, B.; Norman, M. H.; Willoughby, C. A.; Hungate, R.; Reider, P. J.; Biddlecome, G.; Lester-Zeiner, D.; Van Staden, C.; Johnson, E.; Kamassah, A.; Arik, L.; Wang, J.; Viswanadhan, V. N.; Groneberg, R. D.; Zhan, J.; Suzuki, H.; Toro, A.; Mareska, D. A.; Clarke, D. E.; Harvey, D. M.; Burgess, L. E.; Laird, E. R.; Askew, B.; Ng, G. Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity J. Med. Chem. 2007, 50, 607-610
58. Biswas, K.; Li, A.; Chen, J. J.; D'Amico, D. C.; Fotsch, C.; Han, N.; Human, J.; Liu, Q.; Norman, M. H.; Riahi, B.; Yuan, C.; Suzuki, H.; Mareska, D. A.; Zhan, J.; Clarke, D. E.; Toro, A.; Groneberg, R. D.; Burgess, L. E.; Lester-Zeiner, D.; Biddlecome, G.; Manning, B. H.; Arik, L.; Dong, H.; Huang, M.; Kamassah, A.; Loeloff, R.; Sun, H.; Hsieh, F.-Y.; Kumar, G.; Ng, G. Y.; Hungate, R. W.; Askew, B. C.; Johnson, E. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure?activity relationship studies with novel diaminochroman carboxamides J. Med. Chem. 2007, 50, 2200-2212
59. Fotsch, C.; Biddlecome, G.; Biswas, K.; Chen, J. J.; D'Amico, D. C.; Groneberg, R. D.; Han, N. B.; Hsieh, F.-Y.; Kamassah, A.; Kumar, G.; Lester-Zeiner, D.; Liu, Q.; Mareska, D. A.; Riahi, B. B.; Wang, Y. J.; Yang, K.; Zhan, J.; Zhu, J.; Johnson, E.; Ng, G.; Askew, B. C. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core Bioorg. Med. Chem. Lett. 2006, 16, 2071-2075
60. Madden, J.; Hallett, D.; Tayler, S.; Raju, G.; Wang, X.; Gemkow, M. N -Sulfonyl-azacyclic Compounds as Bradykinin B1 Antagonists and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases. WO2008125570, 2008.
61. Dubuisson, D.; Dennis, S. G. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain 1977, 4, 161-74
62. Oberboersch, S.; Schunk, S.; Reich, M.; Hees, S.; Jostock, R.; Engels, M.; Kless, A.; Christoph, T.; Schiene, K.; Germann, T.; Bijsterveld, E. Preparation of 1-(Phenylsulfonyl)piperidines as Bradykinin BK1 Receptor Inhibitors. WO2008040492, 2008.
63. Biswas, K.; Aya, T.; Qian, W.; Peterkin, T. A. N.; Chen, J. J.; Human, J.; Hungate, R. W.; Kumar, G.; Arik, L.; Lester-Zeiner, D.; Biddlecome, G.; Manning, B. H.; Sun, H.; Dong, H.; Huang, M.; Loeloff, R.; Johnson, E. J.; Askew, B. C. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain Bioorg. Med. Chem. Lett. 2008, 18, 4764-4769
64. Ha, S. N.; Hey, P. J.; Ransom, R. W.; Harrell, C. M.; Murphy, K. L.; Chang, R.; Chen, T.-B.; Su, D.-S.; Markowitz, M. K.; Bock, M. G.; Freidinger, R. M.; Hess, F. J. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1 Biochem. Biophys. Res. Commun. 2005, 331, 159-166
65. Chen, J. J.; Qian, W.; Biswas, K.; Viswanadhan, V. N.; Askew, B. C.; Hitchcock, S.; Hungate, R. W.; Arik, L.; Johnson, E. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent bradykinin B1 receptor antagonists Bioorg. Med. Chem. Lett. 2008, 18, 4477-4481
66. Chen, J. J.; Human, J. B.; Qian, W.; Zhu, J. Preparation of N -(1-Arylsulfonyl-3-oxo-1,2,3,4-tetrahydropyrazin-2-yl)acetamide Derivatives as Bradykinin B1 Receptor Antagonists for Treatment of Pain and Inflammation. WO2007067629, 2007.
67. Huszár, J.; Timár, Z.; Szalai, K. K.; Keser?, G.; Fülöp, F.; Penke, B. Novel bradykinin-1 antagonists containing a (1,2,3,4-tetrahydro-isoquinolin-1-yl)acetic acid scaffold Eur. J. Med. Chem. 2008, 43, 1552-1558
68. Huszár, J.; Timár, Z.; Bogar, F.; Penke, B.; Kiss, R.; Szalai, K. K.; Schmidt, E.; Papp, A.; Keser?, G. Aspartic acid scaffold in bradykinin B1 antagonists J. Pept. Sci. 2009, 15, 423-434
69. Cole, A. G.; Metzger, A.; Brescia, M.-R.; Qin, L.-Y.; Appell, K. C.; Brain, C. T.; Hallett, A.; Ganju, P.; Denholm, A. A.; Wareing, J. R.; Ritchie, T. J.; Drake, G. M.; Bevan, S. J.; MacGloinn, A.; McBryde, A.; Patel, V.; Oakley, P. J.; Nunez, X.; Gstach, H.; Schneider, P.; Baldwin, J. J.; Dolle, R. E.; McDonald, E.; Henderson, I. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists Bioorg. Med. Chem. Lett. 2009, 19, 119-122
70. Porreca, F.; Vanderah, T. W.; Guo, W.; Barth, M.; Dodey, P.; Peyrou, V.; Luccarini, J. M.; Junien, J.-L.; Pruneau, D. Antinociceptive pharmacology of N -[[4-(4,5-dihydro-1 H -imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6- dimethylphenyl) sulfonyl]methylamino]ethoxy]- N -methylacetamide fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist J. Pharmacol. Exp. Ther. 2006, 318, 195-205
71. Sevcik, M. A.; Ghilardi, J. R.; Halvorson, K. G.; Lindsay, T. H.; Kubota, K.; Mantyh, P. W. Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model J. Pain 2005, 6, 771-775
72. Hauel, N.; Ceci, A.; Doods, H.; Kauffmann-Hefner, I.; Konetzki, I.; Schuler-Metz, A.; Walter, R. Preparation of Phenylsulfonamides as Analgesics. WO2009021944, 2009.
73. Merla, B.; Oberboersch, S.; Jostock, R.; Engels, M.; Schunk, S.; Reich, M.; Hees, S. Fused-Piperazine-Sulfonamide Derivatives as Bradykinin 1 Receptor Agonists and Antagonists and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases. WO2009090054, 2009.
74. Kauffmann-Hefner, I.; Ceci, A.; Doods, H.; Hauel, N.; Konetzki, I.; Schuler-Metz, A.; Walter, R. Preparation of Phenylsulfonamides as Bradykinin Receptor Antagonists. WO2009013299, 2009.
75. Su, D.-S.; Lim, J. L.; Tinney, E.; Wan, B.-L.; Murphy, K. L.; Reiss, D. R.; Harrell, C. M.; O'Malley, S. S.; Ransom, R. W.; Chang, R. S. L.; Pettibone, D. J.; Yu, J.; Tang, C.; Prueksaritanont, T.; Freidinger, R. M.; Bock, M. G.; Anthony, N. J. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists J. Med. Chem. 2008, 51, 3946-3952
76. Demeule, M.; Regina, A.; Jodoin, J.; Laplante, A.; Dagenais, C.; Berthelet, F.; Moghrabi, A.; Beliveau, R. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood?brain barrier Vasc. Pharmacol. 2002, 38, 339-348
77. Su, D.-S.; Markowitz, M. K.; Murphy, K. L.; Wan, B.-L.; Zrada, M. M.; Harrell, C. M.; O'Malley, S. S.; Hess, J. F.; Ransom, R. W.; Chang, R. S.; Wallace, M. A.; Raab, C. E.; Dean, D. C.; Pettibone, D. J.; Freidinger, R. M.; Bock, M. G. Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies Bioorg. Med. Chem. Lett. 2004, 14, 6045-6048
78. Vago, I.; Farkas, S.; Hornok, K.; Beke, G.; Bozo, E.; Vastag, M.; Szentirmay, E.; Keserue, G.; Schmidt, E. Preparation of Heterocyclyloxoalkyl Phenoxyphenylsulfamoylbenzamides as Bradykinin B1 Receptor Antagonists. WO2009053763, 2009.
79. Ritchie, T. J.; Dziadulewicz, E. K.; Culshaw, A. J.; Mueller, W.; Burgess, G. M.; Bloomfield, G. C.; Drake, G. S.; Dunstan, A. R.; Beattie, D.; Hughes, G. A.; Ganju, P.; McIntyre, P.; Bevan, S. J.; Davis, C.; Yaqoob, M. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B1 receptor based on a 2-alkylamino-5-sulfamoylbenzamide core J. Med. Chem. 2004, 47, 4642-4644
80. Fox, A.; Kaur, S.; Li, B.; Panesar, M.; Saha, U.; Davis, C.; Dragoni, I.; Colley, S.; Ritchie, T.; Bevan, S.; Burgess, G.; McIntyre, P. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor Br. J. Pharmacol. 2005, 144, 889-899
81. Wood, M. R.; Kim, J. J.; Han, W.; Dorsey, B. D.; Homnick, C. F.; DiPardo, R. M.; Kuduk, S. D.; MacNeil, T.; Murphy, K. L.; Lis, E. V.; Ransom, R. W.; Stump, G. L.; Lynch, J. J.; O'Malley, S. S.; Miller, P. J.; Chen, T.-B.; Harrell, C. M.; Chang, R. S. L.; Sandhu, P.; Ellis, J. D.; Bondiskey, P. J.; Pettibone, D. J.; Freidinger, R. M.; Bock, M. G. Benzodiazepines as potent and selective bradykinin B1 antagonists J. Med. Chem. 2003, 46, 1803-1806
82. Kuduk, S. D.; Bock, M. G. Bradykinin B1 receptor antagonists as novel analgesics: A retrospective of selected medicinal chemistry developments Curr. Top. Med. Chem. 2008, 8, 1420-1430
83. Guo, Q.; Chandrasekhar, J.; Ihle, D.; Wustrow, D. J.; Chenard, B. L.; Krause, J. E.; Hutchison, A.; Alderman, D.; Cheng, C.; Cortright, D.; Broom, D.; Kershaw, M. T.; Simmermacher-Mayer, J.; Peng, Y.; Hodgetts, K. J. 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B1 receptor antagonists Bioorg. Med. Chem. Lett. 2008, 18, 5027-5031
84. Patchett, A. A.; Nargund, R. Privileged structures?an update Annu. Rep. Med. Chem. 2000, 35, 289-298
85. Feng, D.-M.; Wai, J. M.; Kuduk, S. D.; Ng, C.; Murphy, K. L.; Ransom, R. W.; Reiss, D.; Chang, R. S. L.; Harrell, C. M.; MacNeil, T.; Tang, C.; Prueksaritanont, T.; Freidinger, R. M.; Pettibone, D. J.; Bock, M. G. 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists Bioorg. Med. Chem. Lett. 2005, 15, 2385-2388
86. Kuduk, S. D.; Chang, R. K.; Ng, C.; Murphy, K. L.; Ransom, R. W.; Tang, C.; Prueksaritanont, T.; Freidinger, R. M.; Pettibone, D. J.; Bock, M. G. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series Bioorg. Med. Chem. Lett. 2005, 15, 3925-3929
87. Su, D.-S.; Lim, J. L.; Markowitz, M. K.; Wan, B.-L.; Murphy, K. L.; Reiss, D. R.; Harrell, C. M.; O'Malley, S. S.; Ransom, R. W.; Chang, R. S. L.; Pettibone, D. J.; Tang, C.; Prueksaritanont, T.; Freidinger, R. M.; Bock, M. G. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes Bioorg. Med. Chem. Lett. 2007, 17, 3006-3009
88. Hochman, J. H.; Yamazaki, M.; Ohe, T.; Lin, J. H. Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug?drug interactions with P-glycoprotein Curr. Drug Metab. 2002, 3, 257-273
89. Tang, C.; Subramanian, R.; Kuo, Y.; Krymgold, S.; Lu, P.; Kuduk, S. D.; Ng, C.; Feng, D.-M.; Elmore, C.; Soli, E.; Ho, J.; Bock, M. G.; Baillie, T. A.; Prueksaritanont, T. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates Chem. Res. Toxicol. 2005, 18, 934-945
90. Kuduk, S. D.; Di Marco, C. N.; Chang, R. K.; Wood, M. R.; Kim, J. J.; Schirripa, K. M.; Murphy, K. L.; Ransom, R. W.; Tang, C.; Torrent, M.; Ha, S.; Prueksaritanont, T.; Pettibone, D. J.; Bock, M. G. 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists Bioorg. Med. Chem. Lett. 2006, 16, 2791-2795
91. Wood, M. R.; Schirripa, K. M.; Kim, J. J.; Wan, B.-L.; Murphy, K. L.; Ransom, R. W.; Chang, R. S. L.; Tang, C.; Prueksaritanont, T.; Detwiler, T. J.; Hettrick, L. A.; Landis, E. R.; Leonard, Y. M.; Krueger, J. A.; Lewis, S. D.; Pettibone, D. J.; Freidinger, R. M.; Bock, M. G. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists J. Med. Chem. 2006, 49, 1231-1234
92. Yamazaki, M.; Neway, W. E.; Ohe, T.; Chen, I.-W.; Rowe, J. F.; Hochman, J. H.; Chiba, M.; Lin, J. H. In vitro substrate identification studies for P-glycoprotein-mediated transport: species difference and predictability of in vivo results J. Pharmacol. Exp. Ther. 2001, 296, 723-735
93. Hess, J. F.; Chen, R. Z.; Hey, P.; Breese, R.; Chang, R. S. L.; Chen, T.-B.; Bock, M. G.; Vogt, T.; Pettibone, D. J. Generation and characterization of a humanized bradykinin B1 receptor mouse Biol. Chem. 2006, 387, 195-201
94. Tang, C.; Carr, B. A.; Poignant, F.; Ma, B.; Polsky-Fisher, S. L.; Kuo, Y.; Strong-Basalyga, K.; Norcross, A.; Richards, K.; Eisenhandler, R.; Carlini, E. J.; Di Marco, C. N.; Kuduk, S. D.; Yu, N. X.; Raab, C. E.; Rushmore, T.; Frederick, C. B.; Bock, M. G.; Prueksaritanont, T. CYP2C75-involved autoinduction of metabolism in rhesus monkeys of MK-0686, a bradykinin B1 receptor antagonist J. Pharmacol. Exp. Ther. 2008, 325, 935-946
95. Bertilsson, G.; Heidrich, J.; Svensson, K.; Asman, M.; Jendeberg, L.; Sydow-Backman, M.; Ohlsson, R.; Postlind, H.; Blomquist, P.; Berkenstam, A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 12208-12213
96. Pichard, L.; Fabre, I.; Fabre, G.; Domergue, J.; Saint Aubert, B.; Mourad, G.; Maurel, P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes Drug Metab. Dispos. 1990, 18, 595-606
97. Kuduk, S. D.; DiPardo, R. M.; Chang, R. K.; Di Marco, C. N.; Murphy, K. L.; Ransom, R. W.; Reiss, D. R.; Tang, C.; Prueksaritanont, T.; Pettibone, D. J.; Bock, M. G. Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series Bioorg. Med. Chem. Lett. 2007, 17, 3608-3612
98. Feng, D.-M.; DiPardo, R. M.; Wai, J. M.; Chang, R. K.; Di Marco, C. N.; Murphy, K. L.; Ransom, R. W.; Reiss, D. R.; Tang, C.; Prueksaritanont, T.; Pettibone, D. J.; Bock, M. G.; Kuduk, S. D. A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity Bioorg. Med. Chem. Lett. 2008, 18, 682-687
99. Locardi, E.; Dinkel, K.; Schaudt, M.; Richter, U.; Scharn, D.; Hummel, G.; Reineke, U.; Reimer, U. Preparation of Pyrrolidinecarbonylbenzylamine Derivatives for Use as Bradykinin B1 Receptor Antagonists. WO2009036996, 2009.
100. Hauel, N.; Ceci, A.; Cereda, E.; Doods, H.; Konetzki, I.; Mack, J.; Priepke, H.; Schuler-Metz, A.; Walter, R. Preparation of Aminocyclopropanecarboxamides as Bradykinin B1 Antagonists. WO2009027450, 2009.
101. Wood, M. R.; Schirripa, K. M.; Kim, J. J.; Kuduk, S. D.; Chang, R. K.; Di Marco, C. N.; DiPardo, R. M.; Wan, B.-L.; Murphy, K. L.; Ransom, R. W.; Chang, R. S. L.; Holahan, M. A.; Cook, J. J.; Lemaire, W.; Mosser, S. D.; Bednar, R. A.; Tang, C.; Prueksaritanont, T.; Wallace, A. A.; Mei, Q.; Yu, J.; Bohn, D. L.; Clayton, F. C.; Adarayn, E. D.; Sitko, G. R.; Leonard, Y. M.; Freidinger, R. M.; Pettibone, D. J.; Bock, M. G. ?-Hydroxy amides as a novel class of bradykinin B1 selective antagonists Bioorg. Med. Chem. Lett. 2008, 18, 716-720
102. Kuduk, S. D.; Chang, R. K.; DiPardo, R. M.; Di Marco, C. N.; Murphy, K. L.; Ransom, R. W.; Reiss, D. R.; Tang, C.; Prueksaritanont, T.; Pettibone, D. J.; Bock, M. G. Bradykinin B1 receptor antagonists: an ?-hydroxy amide with an improved metabolism profile Bioorg. Med. Chem. Lett. 2008, 18, 5107-5110
103. Horlick, R. A.; Ohlmeyer, M. H.; Stroke, I. L.; Strohl, B.; Pan, G.; Schilling, A. E.; Paradkar, V.; Quintero, J. G.; You, M.; Riviello, C.; Thorn, M. B.; Damaj, B.; Fitzpatrick, V. D.; Dolle, R. E.; Webb, M. L.; Baldwin, J. J.; Sigal, N. H. Small molecule antagonists of the bradykinin B1 receptor Immunopharmacology 1999, 43, 169-177
104. Ohlmeyer, H. J.; Baldwin, J. J.; Dolle, R. E.; Paradkar, V.; Quintero, J. G.; Pan, G. Bradykinin B1 Receptor Antagonists. WO200105783, 2001.
105. Hawkinson, J. E.; Szoke, B. G.; Garofalo, A. W.; Hom, D. S.; Zhang, H.; Dreyer, M.; Fukuda, J. Y.; Chen, L.; Samant, B.; Simmonds, S.; Zeitz, K. P.; Wadsworth, A.; Liao, A.; Chavez, R. A.; Zmolek, W.; Ruslim, L.; Bova, M. P.; Holcomb, R.; Butelman, E. R.; Ko, M.-C.; Malmberg, A. B. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 receptor antagonist ELN441958 J. Pharmacol. Exp. Ther. 2007, 322, 619-630
106. Dressen, D.; Garofalo, A. W.; Hawkinson, J.; Hom, D.; Jagodzinski, J.; Marugg, J. L.; Neitzel, M. L.; Pleiss, M. A.; Szoke, B.; Tung, J. S.; Wone, D. W. G.; Wu, J.; Zhang, H. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists J. Med. Chem. 2007, 50, 5161-5167
107. Murphy, R. C.; Watkins, W. D. Pharmacology of pyrazoles. I. Structure elucidation of metabolites of 4-methylpyrazole Biochem. Biophys. Res. Commun. 1972, 49, 283-291
108. Clay, K. L.; Watkins, W. D.; Murphy, R. C. Metabolism of pyrazole. Structure elucidation of urinary metabolites Drug Metab. Dispos. 1977, 5, 149-156
109. Whitaker, N. G. G.; Lindstrom, T. D. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys Drug Metab. Dispos. 1987, 15, 107-113
110. Chen, J. J.; Biswas, K. Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain Prog. Med. Chem. 2008, 46, 173-204